Abstract
Background:
Current diagnosis of Helicobacter pylori infection by biopsy-based tests requires invasive sampling. Non-invasive methods such as the H. pylori stool-antigen (HpSA) test may be the best alternative for diagnosis of active infection. However, due to the presence of antigenic-diversity among the strains, various commercial tests have shown some discrepancies in different geographical-areas.Objectives:
This study evaluates a homemade HpSA kit developed by using the H. pylori antigens from Iranian-isolates for detection of H. pylori in the stool of infected patients.Patients and Methods:
Based on the endoscopic features and/or a rapid-urease test (RUT), 30 child and 50 adult patients, were recruited. From these candidates, three biopsies for RUT, culture and histology, and a stool-sample, were obtained. Patients were considered as H. pylori-positive if culture alone or RUT plus histology were found to be positive. Presence of H. pylori antigens in their stools was detected by the homemade HpSA test and an imported HpSA kit (Immundiagnostik, Germany).Results:
Using the biopsy-based tests with RUT, histology and culture, 53% (16/30) of children were diagnosed as H. pylori–positive while using the imported kit 57% and the homemade kit 50% of the candidates showed positive results. Also by the biopsy-based tests, 54% of the adults were diagnosed as H. pylori-positive while by the homemade kit 56% showed positive results. Considering the biopsy-based tests as the gold standard, sensitivity and specificity for the imported kit was 94% and 86%, respectively, while the mean sensitivity and specificity for the homemade kit was 96% and 98%, respectively.Conclusions:
The homemade kit, compared with the imported kit and biopsy-proven tests may be a valid and reliable method for determining the presence of H. pylori infection in Iran.Keywords
1. Background
Helicobacter pylori infect more than half of the adult and children in developing countries (1). The rate of infection in the Iranian population is, up to 80% in adults and around 50% in children (2-4). The relationship between chronic infection by H. pylori and stomach ulcers, duodenal ulcers and stomach adenocarcinoma has been established and to avoid these outcomes, early identification and treatment of infection is required (5, 6). The methods, which are currently used for the diagnosis of H. pylori infection, include culture, histology and rapid urease tests (7, 8). Although they are all accurate, yet they require invasive sampling after endoscopy. Non-invasive methods, which are based on analysis of sera or breath, also have some disadvantages.
Serological tests are unable to distinguish active from past infections since the presence of anti-H. pylori antibodies in serum do not necessarily indicate current infection by H. pylori. Serology, only has a place for epidemiological studies since after eradication, the decrease of antibody titer is very slow and remains positive in more than 30% of cases, after one year (9-11). C-13 urea breath test is a very good non-invasive test, comparable with the stool antigen test. Urease breath test has been shown to be excellent in performance, yet is not always available in routine clinical laboratories especially in developing countries (12-15). In addition, it has been associated with some disadvantages for infants and very young children, as well as patients with certain neurological disorders (12, 14, 15).
By gastric colonization, H. pylori are excreted into the stool and their amount in the stool may be related to the degree of stomach colonization by bacteria (16-18). Thus, their presence in the stool can be detected by H. pylori stool-antigen (HpSA), PCR or even culture methods (16, 18). Among stool-based tests, HpSA test has been known as a simple, relatively inexpensive and reliable assay for the diagnosis of H. pylori infection in adults and children (19, 20). For this purpose, various commercial tests using polyclonal or monoclonal anti-H. pylori antibodies have been developed (19, 21-24). However, the results of population screenings by these kits have shown some discrepancies in different geographical areas especially with tests using monoclonal antibodies (17, 19, 21, 23).
2. Objectives
The purpose of this study was to evaluate a homemade HpSA kit, previously developed by using the H. pylori antigens from Iranian isolates for the detection of H. pylori in the stool of infected patients. This evaluation was performed by detection of H. pylori antigens in the stool of child and adult control patients diagnosed as H. pylori-positive or H. pylori-negative by biopsy based tests.
3. Patients and Methods
3.1. Patients and Biopsy-Based Tests
Two groups of patients were selected for this study from which an informed consent was obtained before the endoscopy. The first group included 30 children (aged 3-14 years) recruited from patients admitted to the Children Medical Center of Tehran, who had symptoms and endoscopic features of peptic ulcer diseases and/or a positive rapid-urease test (RUT) in the endoscopy room. From these cases, two antral biopsies similar to that of RUT were obtained for culture and for histological examination and staining. Their first stool after endoscopy but before antibiotic therapy was collected and stored at -70℃ until use. The second group included 50 adults (aged 19-60 years) recruited from patients undergoing endoscopic examinations at Shariati Hospital in Tehran who had clinical symptoms of H. pylori infection or a positive RUT at the endoscopy room. For this group, the first stool specimen after endoscopy was also obtained and stored at -70℃ until use.
Culture of biopsy samples was performed as previously described and the grown colonies were identified by Gram-staining, oxidase, urease and PCR according to a previously described protocol (18). RUT was performed using urea broth as previously described (4). Histological examination of the biopsies was performed after Hematoxilin & Eosin and Geimsa staining. H. pylori density, gastritis and inflammation was graded according to standard protocols (8, 25). The status of H. pylori infection in the patients was evaluated according to the results of biopsy-based tests. A patient was considered as a H. pylori-positive control if biopsy culture alone or histology plus rapid urease test (RUT) was positive. These positives were used as the gold standards.
3.2. Imported HpSA Test Used in This Work
The imported HpSA test (H. pylori Antigen ELISA Kit, Immun Diagnostik, Germany) is based on a sandwich ELISA for detection of H. pylori in the stool. In this kit, a microtiter plate is coated with polyclonal antibodies specific for H. pylori, which bind H. pylori antigens from the patient sample in the first incubation step. After a washing step, the bound antigens are incubated with a biotin-labeled antibody. After a further washing step, a peroxidase-labeled streptavidin is added. Then a chromogenic substrate (TMB) is added, which produces a blue color; addition of stop solution changes this color to yellow. The intensity of the color is proportional to the amount of analyte (sample or control).
The results are evaluated by comparison with a cut-off value, which is 0.150 at 450/620 nm and 0.190 at 450 nm. Thus, the samples with an absorbance more than 0.020 (measurement at 450/620 nm) or 0.025 (measurement at 450 nm) above the cut off-value are considered as positive and samples with an absorbance more than 0.020 (0,025) under the cut off-value are classified as negative. In this assay, absorption of the negative control at 450 nm should be less than 0.190 and that of the positive control should be greater than 0.50.
3.3. Initial Standardization of the Homemade HpSA Test
This test is essentially based on employment of the local H. pylori antigens. The local H. pylori strain, used for immunization of rabbits, was selected from a collection of H. pylori strains isolated from this region (26, 27). This selection was based on its conserved SDS-PAGE outer membrane proteins profile among strains isolated from subjects with more severe pathology of H. pylori infection (27). To analyze the efficiency of the immune responses produced against H. pylori PP23 in rabbits and to obtain its titer, the anti-H. pylori specific antibodies were tested with multiple H. pylori antigens including the local and the imported H. pylori antigens. For this purpose, the 96 microwell plates were coated with 5μg/ml of H. pylori antigens from PP23 and PP157 strains (26) and with H. pylori antigens from H. pylori Antigen ELISA Kit (Immun Diagnostik, Germany).
The ELISA assay was performed using serial dilutions of anti-PP23 antibody prepared in rabbits. In this initial study, a reaction was considered positive for antibodies to H. pylori if the absorbance of the reaction was > 0.5 at 450 nm and the last dilution of anti-H. pylori antibodies, which generated a positive reaction, was selected. This experiment was repeated and the best results were obtained from a checkerboard curve. To evaluate the minimal concentration of bacteria in stool necessary to generate a positive reaction, 1 mL portions of suspensions from strains PP23 and PP157 (26), with turbidities equivalent to those of McFarland 0.5 to 5 standards, were inoculated into the tubes containing 0.4 g of stool obtained from a negative control (a healthy subject with negative results for RUT, culture and histology tests). The stool samples, which were seeded with bacterial suspensions, were tested by the capture ELISA assay and the initial concentrations of bacteria inoculated into each stool sample was determined by CFU analysis. Next, the minimal concentration of bacteria required to generate a positive reaction was determined by comparison of OD at 450 nm between stool samples seeded with bacteria and the negative control. It was concluded that the presence of 100 bacteria in a stool sample was sufficient to generate a positive reaction. Thus, an initial optical density for the negative and the positive stools (the threshold for a negative and positive) was defined as the assay detection limits.
3.4. Homemade HpSA Test
This homemade HpSA test was based on a capture ELISA for detection of H. pylori in stools. Briefly, a 96 microwell plate (Nunc GmbH, Germany), was coated with anti-H. pylori antibodies prepared against membrane associated H. pylori antigens from the PP23 H. pylori strain (26, 27). These coated plates were blocked with 1% BSA in PBS (pH = 7.2) for one hour. For stool antigen preparation, a small portion of stool (0.2 g) was transferred into a vial containing 1 ml of extraction buffer by using the applicator stick, vortexed for 15 seconds and centrifuged for 10 minutes at 400 to 500 × g. One hundred microliters of the supernatant was transferred into each well and incubated at 37°C for one hour and 30 minutes. The wells were washed and incubated with the goat anti-rabbit polyvalent antibody conjugated with horseradish peroxidase (Sigma) for one hour. Next, a chromogenic substrate 3, 3’, 5, 5’ Tetramethylbenzidine, (Sigma) was added. After 20 minutes of incubation, a stop solution (1 N hydrochloric acid) was added and the intensity of the color was measured at 450 nm. The positive control was inactivated H. pylori antigens (in buffered solution, pH = 7.0) from PP23 and PP157 strains (26). The negative control was inactivated Staphylococcus aureus antigens (in buffered solution, pH = 7.0) from ATCC 25923 strain.
3.5. Determination of the HpSA Status and Validation of the Cut Off Value
Using the Homemade HpSA test, the stool samples from control, children and adult groups were screened for the presence of H. pylori. This experiment was repeated three times and the status of HpSA-positivity or HpSA-negativity was determined by comparison of the results. The stool samples from the children group were also screened by the imported HpSA kit (H. pylori Antigen ELISA Kit, Immun Diagnostik, Germany). The results of these screening were used for designing a threshold for positive and negative stool antigen result. So a cut-off value of 0.230 ± 0.025 at 450 nm was selected. For calculating the sensitivity and specificity of the HpSA tests, the positive HpSA results, which corresponded to the patients with a positive status (based on biopsy based tests), were considered as the true positives. The false positive or the false negative HpSA tests were those negative by biopsy-based tests but positive by HpSA or positive by biopsy-based tests but negative by HpSA tests, respectively.
4. Results
4.1. Biopsy Based Tests Results
Of the 30 children included in the first part of this study, 16 patients (53%) were classified as H. pylori positive by biopsy-based tests. Amongst these cases, eight had positive results for all of the three tests, four for RUT and histology, three for both RUT and culture, and one had a positive result only for the culture test. Twenty-six of these cases had endoscopic features of non-ulcer and four had the status of ulcer. Of the fifty adult patients recruited from Shariati Hospital, 27 (54%) were classified as H. pylori positive by biopsy-based tests. Amongst these patients, eight had positive results for all three tests, 16 for both RUT and histology, and three for both RUT and culture. The patients positive for H. pylori infection showed nodular and erosive gastritis, gastric ulcer, duodenal ulcer, gastroduodenal ulcer and atrophy.
4.2. HpSA Tests Results
The results of HpSA tests for the groups of children and adult controls are shown in Tables 1, 2, respectively. The values of sensitivity and specificity of the HpSA tests are shown in Table 3. These results demonstrate that mean sensitivity and specificity of the homemade test was 97% and 98%, respectively.
Comparison Between the Results of Biopsy-Based Tests and HpSA Tests for Diagnosis of H. pylori Infection in the Child Control Patients
| Number of Patient | Status of H. pylori Infection | RUT | Culture | Histology | HpSA Imported | HpSA Homemade |
|---|---|---|---|---|---|---|
| m1 | negative | negative | negative | negative | negative | negative |
| m2 | negative | negative | negative | negative | negative | negative |
| m3 | negative | negative | negative | negative | negative | negative |
| m4 | negative | negative | negative | negative | positive | negative |
| m5 | positive | negative | positive | negative | positive | positive |
| m6 | negative | negative | negative | negative | negative | negative |
| m8 | negative | negative | negative | negative | negative | negative |
| m9 | positive | positive | negative | positive | positive | positive |
| m10 | negative | positive | negative | negative | negative | negative |
| m11 | negative | negative | negative | negative | negative | negative |
| m12 | positive | positive | positive | negative | positive | positive |
| m13 | negative | negative | negative | negative | negative | negative |
| m14 | positive | positive | positive | positive | positive | positive |
| m15 | positive | positive | positive | negative | positive | positive |
| m16 | positive | positive | negative | positive | positive | positive |
| m17 | positive | positive | positive | positive | positive | positive |
| m18 | positive | positive | positive | positive | positive | positive |
| m19 | positive | positive | positive | positive | positive | positive |
| m20 | positive | positive | positive | positive | positive | positive |
| m21 | negative | negative | negative | negative | negative | negative |
| m22 | positive | positive | negative | positive | positive | positive |
| m23 | negative | negative | negative | negative | negative | negative |
| m24 | negative | negative | negative | negative | negative | negative |
| m25 | positive | positive | positive | positive | positive | positive |
| m26 | negative | positive | negative | negative | negative | negative |
| m28 | positive | positive | positive | negative | negative | negative |
| m29 | positive | positive | negative | positive | positive | positive |
| m30 | negative | positive | negative | negative | positive | negative |
| m32 | positive | positive | positive | positive | positive | positive |
| m33 | positive | positive | positive | positive | positive | positive |
Comparison Between the Results of Biopsy-Based Tests and HpSA Test for Diagnosis of H. pylori Infection in Control Adult Patients a
| Number of Patient | Status of H. pylori Infection | RUT | Culture | Histology of H. pylori | HpSA Homemade |
|---|---|---|---|---|---|
| 1 | negative | negative | negative | negative | negative |
| 2 | negative | positive | negative | negative | negative |
| 3 | positive | positive | positive | negative | positive |
| 4 | positive | positive | negative | positive | positive |
| 5 | negative | negative | negative | negative | negative |
| 6 | positive | positive | positive | negative | positive |
| 7 | positive | positive | ND | positive | positive |
| 8 | negative | negative | negative | ND | negative |
| 9 | negative | negative | negative | negative | positive |
| 10 | negative | negative | negative | negative | negative |
| 11 | positive | positive | positive | positive | positive |
| 12 | positive | positive | positive | positive | positive |
| 13 | positive | positive | ND | positive | positive |
| 14 | positive | positive | ND | positive | positive |
| 15 | negative | negative | negative | positive | negative |
| 16 | positive | positive | negative | positive | positive |
| 17 | positive | positive | positive | positive | positive |
| 18 | negative | negative | negative | negative | negative |
| 19 | negative | negative | negative | negative | negative |
| 20 | positive | positive | positive | positive | positive |
| 21 | positive | positive | positive | positive | positive |
| 22 | positive | positive | positive | positive | positive |
| 23 | positive | positive | ND | positive | positive |
| 24 | negative | negative | negative | negative | negative |
| 25 | negative | negative | negative | ND | negative |
| 26 | negative | negative | negative | ND | negative |
| 27 | negative | negative | negative | negative | negative |
| 28 | negative | negative | negative | negative | negative |
| 29 | positive | positive | positive | ND | positive |
| 30 | positive | positive | negative | positive | positive |
| 31 | positive | positive | positive | positive | positive |
| 32 | negative | negative | negative | negative | negative |
| 33 | negative | negative | negative | ND | negative |
| 34 | positive | positive | negative | positive | positive |
| 35 | positive | positive | negative | positive | positive |
| 36 | negative | negative | negative | negative | negative |
| 37 | positive | positive | negative | positive | positive |
| 38 | negative | negative | ND | negative | negative |
| 39 | positive | positive | negative | positive | positive |
| 40 | negative | negative | negative | positive | negative |
| 41 | positive | positive | positive | positive | positive |
| 42 | positive | positive | positive | ND | positive |
| 43 | negative | positive | negative | negative | negative |
| 44 | negative | negative | negative | negative | negative |
| 45 | negative | negative | negative | negative | negative |
| 46 | positive | positive | ND | positive | positive |
| 47 | positive | positive | negative | positive | positive |
| 48 | positive | positive | ND | positive | positive |
| 49 | negative | negative | negative | negative | negative |
| 50 | positive | positive | ND | positive | positive |
5. Discussion
During the last few years, non-invasive methods for the detection of H. pylori infection are increasingly exploited, especially those using the ELISA assays. One important advantage of these non-invasive methods is that discomfort and risk of invasive endoscopy is avoided. Among the non-invasive tests, the stool antigen test ha been approved by the authorities since it distinguishes patients with active infection from the subjects with only the precedence of H. pylori infection (28, 29). Several HpSA tests based on polyclonal and monoclonal antibodies against H. pylori antigens have been developed, which detect the presence of fecal antigens of H. pylori, however, their diagnostic accuracy is controversial in various geographical regions (17, 21, 24).
One reason for the presence of discrepancies among the accuracy of these assays may be the presence of significant heterogeneity among H. pylori strains especially among those from different geographic regions. Another problem may be the occurrence of cross reactivity with other enteric pathogens which produces uncertain results and may be due to non-adjustment of the cut off values. This possibility was excluded in the case of the HpSA assay, presented in this work. Antibody molecules are highly specific for their corresponding antigens, being able to detect one molecule of a protein antigen out of more than 108 similar molecules (30, 31). This high specificity may be responsible for the high specificity of the tests based on employment of the monoclonal antibodies. However, due to the presence of vast molecular heterogeneity among H. pylori strains, a monoclonal antibody prepared against a distinct antigenic determinant, would not necessarily recognize a similar one in another strain. Thus, in many cases, the sensitivities of the tests based on monoclonal antibodies are not similar, especially in geographically different regions. This inconvenience could be lower in cases of tests based on polyclonal antibodies, which have the potential to recognize numerous antigenic determinants.
In Iran, various HpSA ELISA imported kits have been tested, however, their accuracy in the Iranian population may not be similar (3, 20, 32). Using 16 H. pylori positive and 14 H. pylori negative child patients as the gold standard group, a higher sensitivity and specificity was obtained with the Homemade HpSA kit in comparison with the Imported kit (Table 1). Although the sensitivity and specificity of this imported kit was evaluated as 97.7% and 96.3%, respectively, by the manufacturer, these values were lower in the case of Iranian H. pylori, suggesting its lower performance in a geographically different region, such as Iran. This is the first report evaluating and comparing the sensitivity and specificity of commercially imported HpSA ELISA kits with an Iranian homemade kit (based on local H. pylori antigens) for detection of H. pylori-specific antigens. Presence of significant molecular heterogeneity amongst Iranian and H. pylori strains from other regions of the world, impose the development of an HpSA ELISA kit by using local antigens. The results of this evaluation have shown that the homemade HpSA kit, compared with the imported kit and biopsy-proven tests may be a valid and reliable method for checking the presence of H. pylori infection in Iran.
Acknowledgements
References
-
1.
Kikuchi S, Dore MP. Epidemiology of Helicobacter pylori Infection. Helicobacter. 2005;10 Suppl 1:1-4. [PubMed ID: 16178964]. https://doi.org/10.1111/j.1523-5378.2005.00335.x.
-
2.
Massarrat S, Saberi-Firoozi M, Soleimani A, Himmelmann GW, Hitzges M, Keshavarz H. Peptic ulcer disease, irritable bowel syndrome and constipation in two populations in Iran. Eur J Gastroenterol Hepatol. 1995;7(5):427-33. [PubMed ID: 7614105].
-
3.
Alborzi A, Soltani J, Pourabbas B, Oboodi B, Haghighat M, Hayati M, et al. Prevalence of Helicobacter pylori infection in children (south of Iran). Diagn Microbiol Infect Dis. 2006;54(4):259-61. [PubMed ID: 16466888]. https://doi.org/10.1016/j.diagmicrobio.2005.10.012.
-
4.
Falsafi T, Valizadeh N, Sepehr S, Najafi M. Application of a stool antigen test to evaluate the incidence of Helicobacter pylori infection in children and adolescents from Tehran, Iran. Clin Diagn Lab Immunol. 2005;12(9):1094-7. [PubMed ID: 16148176]. https://doi.org/10.1128/CDLI.12.9.1094-1097.2005.
-
5.
Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev. 2006;19(3):449-90. [PubMed ID: 16847081]. https://doi.org/10.1128/CMR.00054-05.
-
6.
Fischbach W, Chan AO, Wong BC. Helicobacter pylori and Gastric Malignancy. Helicobacter. 2005;10 Suppl 1:34-9. [PubMed ID: 16178969]. https://doi.org/10.1111/j.1523-5378.2005.00338.x.
-
7.
Cirak MY, Akyon Y, Megraud F. Diagnosis of Helicobacter pylori. Helicobacter. 2007;12 Suppl 1:4-9. [PubMed ID: 17727453]. https://doi.org/10.1111/j.1523-5378.2007.00542.x.
-
8.
NAjafi Sani M, Kianifar HR, Khodadad A, Ahmadi M, Falsafi T, Khatami G. Endoscopic Nodular Gastritis: An Indicator of Helicobacter Pylori Infection in Children. Med J Islam Repub Iran. 2005;19(3):195-9.
-
9.
Han FC, Li XJ, Jiang H, Qin LP, Li D, Guo YH, et al. Detection of H. pylori antibody profile in serum by protein array. World J Gastroenterol. 2006;12(25):4044-8. [PubMed ID: 16810756].
-
10.
Sokucu S, Ozden AT, Suoglu OD, Elkabes B, Demir F, Cevikbas U, et al. CagA positivity and its association with gastroduodenal disease in Turkish children undergoing endoscopic investigation. J Gastroenterol. 2006;41(6):533-9. [PubMed ID: 16868800]. https://doi.org/10.1007/s00535-006-1788-z.
-
11.
Manjunath SM, Desai ND, Alexander J, Patil S, Ughade S, Sawant P. Can anti-Helicobacter pylori and anti-CagA antibodies be used to select patients with dyspepsia for gastroscopy? Trop Gastroenterol. 2006;27(3):122-6. [PubMed ID: 17310555].
-
12.
Mauro M, Radovic V, Wolfe M, Kamath M, Bercik P, Armstrong D. 13C urea breath test for (Helicobacter pylori): evaluation of 10-minute breath collection. Can J Gastroenterol. 2006;20(12):775-8. [PubMed ID: 17171196].
-
13.
Yong CS, Kim YI, Park SM, Kwon R, Han HH, Park JG, et al. Trials of novel 13C-urea-containing capsule for more economic and sensitive diagnosis of Helicobacter pylori infection in human subjects. Arch Pharm Res. 2006;29(10):879-83. [PubMed ID: 17121183].
-
14.
Krogfelt KA, Lehours P, Megraud F. Diagnosis of Helicobacter pylori Infection. Helicobacter. 2005;10 Suppl 1:5-13. [PubMed ID: 16178965]. https://doi.org/10.1111/j.1523-5378.2005.00341.x.
-
15.
Monteiro L, de Mascarel A, Sarrasqueta AM, Bergey B, Barberis C, Talby P, et al. Diagnosis of Helicobacter pylori infection: noninvasive methods compared to invasive methods and evaluation of two new tests. Am J Gastroenterol. 2001;96(2):353-8. [PubMed ID: 11232675]. https://doi.org/10.1111/j.1572-0241.2001.03518.x.
-
16.
Kabir S. Detection of Helicobacter pylori in faeces by culture, PCR and enzyme immunoassay. J Med Microbiol. 2001;50(12):1021-9. [PubMed ID: 11761185].
-
17.
Hooton C, Keohane J, Clair J, Azam M, O'Mahony S, Crosbie O, et al. Comparison of three stool antigen assays with the 13C- urea breath test for the primary diagnosis of Helicobacter pylori infection and monitoring treatment outcome. Eur J Gastroenterol Hepatol. 2006;18(6):595-9. [PubMed ID: 16702847].
-
18.
Falsafi T, Favaedi R, Mahjoub F, Najafi M. Application of stool-PCR test for diagnosis of Helicobacter pylori infection in children. World J Gastroenterol. 2009;15(4):484-8. [PubMed ID: 19152455].
-
19.
Kolho KL, Klemola T, Koivusalo A, Rautelin H. Stool antigen tests for the detection of Helicobacter pylori in children. Diagn Microbiol Infect Dis. 2006;55(4):269-73. [PubMed ID: 16626908]. https://doi.org/10.1016/j.diagmicrobio.2006.02.004.
-
20.
Falaknazi K, Jalalzadeh M, Vafaeimanesh J. Noninvasive stool antigen assay for screening of Helicobacter pylori infection and assessing success of eradication therapy in patients on hemodialysis. Iran J Kidney Dis. 2010;4(4):317-21. [PubMed ID: 20852374].
-
21.
Dominguez J, Forne M, Blanco S, Prat C, Gali N, Latorre I, et al. Comparison of a monoclonal with a polyclonal antibody-based enzyme immunoassay stool test in diagnosing Helicobacter pylori infection before and after eradication therapy. Aliment Pharmacol Ther. 2006;23(12):1735-40. [PubMed ID: 16817917]. https://doi.org/10.1111/j.1365-2036.2006.02936.x.
-
22.
Gisbert JP, de la Morena F, Abraira V. Accuracy of monoclonal stool antigen test for the diagnosis of H. pylori infection: a systematic review and meta-analysis. Am J Gastroenterol. 2006;101(8):1921-30. [PubMed ID: 16780557]. https://doi.org/10.1111/j.1572-0241.2006.00668.x.
-
23.
Quesada M, Calvet X, Dosal A, Calvet V, Sanfeliu I, Ribera L, et al. Evaluation of four different fecal tests for determination of cure after Helicobacter pylori treatment. J Clin Gastroenterol. 2006;40(9):790-4. [PubMed ID: 17016133]. https://doi.org/10.1097/01.mcg.0000225606.18234.38.
-
24.
Frenck RW, Jr, Fathy HM, Sherif M, Mohran Z, El Mohammedy H, Francis W, et al. Sensitivity and specificity of various tests for the diagnosis of Helicobacter pylori in Egyptian children. Pediatrics. 2006;118(4):e1195-202. [PubMed ID: 16982805]. https://doi.org/10.1542/peds.2005-2925.
-
25.
Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996;20(10):1161-81. [PubMed ID: 8827022].
-
26.
Falsafi T. Association between efficient adhesion to HEp-2 cells and severity of gastritis in Helicobacter pylori strains isolated from children. Iran J Microbiol. 2009;1(1):23-30.
-
27.
Eslami-Tehrani B, Falsafi T. SDS-PAGE analysis of the Sarcosine-insoluble outer membrane fraction of the Clinical Isolates of Helicobacter pylori.In: Eslami-Tehrani B, Falsafi T, editors. 10th Iranian Congress of Biochemistry & 3th International Congress of Biochemistry and Molecular Biology. 2009; Tehran, IR Iran.
-
28.
Ghose C, Perez-Perez GI, Torres VJ, Crosatti M, Nomura A, Peek RW, Jr, et al. Serological assays for identification of human gastric colonization by Helicobacter pylori strains expressing VacA m1 or m2. Clin Vaccine Immunol. 2007;14(4):442-50. [PubMed ID: 17267587]. https://doi.org/10.1128/CVI.00434-06.
-
29.
Nurgalieva ZZ, Opekun AR, Graham DY. Problem of distinguishing false-positive tests from acute or transient Helicobacter pylori infections. Helicobacter. 2006;11(2):69-74. [PubMed ID: 16579835]. https://doi.org/10.1111/j.1523-5378.2006.00380.x.
-
30.
Poljak RJ. Structure of antibodies and their complexes with antigens. Mol Immunol. 1991;28(12):1341-5. https://doi.org/10.1016/0161-5890(91)90036-J.
-
31.
Max EE. Paul WE, editor. Immunoglobulins: molecular genetics. 3rd ed. New York: Raven Press; 1993.
-
32.
Talaiezadeh A, Borhani M, Moosavian M, Rafiei A, Kazem Neisi A, Hajiani E, et al. Prevalence of Helicobacter pylori Infection evaluated by Stool antigen test in Khuzestan Province since September to October 2009, south-west of Iran: a population based study. Jundishapur J Microbiol. 2013;6(2):100-4. https://doi.org/10.5812/jjm.4545.